CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma

Published:2020-02-10 Issue:5 Volume:50 Page:712-724
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Liu Guangna¹,Rui Wei¹,Zheng Hongli¹,Huang Daosheng¹,Yu Fei²,Zhang Yuewei²,Dong Jiahong²,Zhao Xueqiang¹,Lin Xin¹³^ORCID

Affiliation:

1. Department of Basic Medical Sciences and Institute for ImmunologyTsinghua University School of Medicine Beijing China

2. Center of Hepatopancreatobiliary Diseases, Beijing Tsinghua Changgung HospitalTsinghua University, School of Medicine Beijing China

3. Tsinghua University‐Peking University Jointed Center for Life Sciences Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201948457

Reference32 articles.

1. Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

2. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

3. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies

4. A guide to chemokines and their receptors

5. Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of TaqMan-based real-time PCR based on ψ gene for quantitative detection of CAR-T cells;Analytical Biochemistry;2024-11

2. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

3. Reprogramming natural killer cells for cancer therapy;Molecular Therapy;2024-09

4. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

5. IL-21- and CXCL9-engineered GPC3-specific CAR-T cells combined with PD-1 blockade enhance cytotoxic activities against hepatocellular carcinoma;Clinical and Experimental Medicine;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3